2022
Segmental basaloid follicular hamartomas derive from a post‐zygotic SMO p.L412F pathogenic variant and express hair follicle development‐related proteins in a pattern that distinguish them from basal cell carcinomas
Atzmony L, Ugwu N, Bercovitch LG, Robinson‐Bostom L, Ko CJ, Myung P, Choate KA. Segmental basaloid follicular hamartomas derive from a post‐zygotic SMO p.L412F pathogenic variant and express hair follicle development‐related proteins in a pattern that distinguish them from basal cell carcinomas. American Journal Of Medical Genetics Part A 2022, 188: 3525-3530. PMID: 35972041, PMCID: PMC9669121, DOI: 10.1002/ajmg.a.62951.Peer-Reviewed Original ResearchConceptsBasal cell carcinomaCell carcinomaFollicular hamartomaProliferation indexBasaloid skin tumorsSporadic basal cell carcinomasBasaloid follicular hamartomaKi-67 expressionLow proliferation indexCentral nervous systemWhole-exome sequencingSystemic involvementExpression of hedgehogMultiple lesionsSkin tumorsWnt/beta-catenin pathwayBasaloid lesionsNervous systemVariable involvementPathogenic variantsSegmental distributionPost-zygotic mutational eventSOX-9 expressionNormal tissuesExome sequencing
2020
Cutaneous Involvement by Mantle Cell Lymphoma: Expanding the Spectrum of Histopathologic Findings in a Series of 9 Cases.
Panse G, Cowper S, Ko CJ, Subtil A. Cutaneous Involvement by Mantle Cell Lymphoma: Expanding the Spectrum of Histopathologic Findings in a Series of 9 Cases. American Journal Of Dermatopathology 2020, 42: 848-853. PMID: 32675465, DOI: 10.1097/dad.0000000000001742.Peer-Reviewed Case Reports and Technical NotesConceptsMantle cell lymphomaCutaneous involvementCell lymphomaSystemic mantle cell lymphomaAggressive B-cell neoplasmSingle institutional seriesSame biopsy specimenSite of involvementMarginal zone lymphomaB-cell neoplasmsImmunoglobulin M expressionSurface IgM expressionInstitutional seriesSecond malignanciesSystemic involvementClinicopathologic featuresCutaneous lesionsSitu hybridization studiesBiopsy specimenHistopathologic findingsMetastatic melanomaFirst manifestationDirect immunofluorescenceHematolymphoid neoplasmsTissue manifestationsPrimary dural lymphomas: Clinical presentation, management, and outcome
Karschnia P, Batchelor TT, Jordan JT, Shaw B, Winter SF, Barbiero FJ, Kaulen LD, Thon N, Tonn J, Huttner AJ, Fulbright RK, Loeffler J, Dietrich J, Baehring JM. Primary dural lymphomas: Clinical presentation, management, and outcome. Cancer 2020, 126: 2811-2820. PMID: 32176324, DOI: 10.1002/cncr.32834.Peer-Reviewed Original ResearchConceptsPrimary dural lymphomaPrimary CNS lymphomaNon-Hodgkin lymphomaCNS lymphomaOverall survivalDural lymphomaPrimary central nervous system lymphomaT-cell non-Hodgkin lymphomaB-cell non-Hodgkin lymphomaCentral nervous system lymphomaLarge B-cell lymphomaMedian apparent diffusion coefficient (ADC) valuesAvid contrast enhancementMedian overall survivalCerebrospinal fluid analysisNervous system lymphomaMarginal zone lymphomaB-cell lymphomaExtra-axial massApparent diffusion coefficient (ADC) valuesMassachusetts General HospitalAggressive surgeryMultimodality treatmentSystem lymphomaSystemic involvement
2017
Topical drug-induced subacute cutaneous lupus erythematosus isolated to the hands
Ramachandran SM, Leventhal JS, Franco LG, Mir A, Walters RF, Franks AG. Topical drug-induced subacute cutaneous lupus erythematosus isolated to the hands. Lupus Science & Medicine 2017, 4: e000207. PMID: 28331627, PMCID: PMC5353283, DOI: 10.1136/lupus-2017-000207.Peer-Reviewed Original ResearchDrug-induced SCLECutaneous lupus erythematosusLupus erythematosusTopical terbinafineUnique presentationDrug-induced subacute cutaneous lupus erythematosusSSA/Ro antibodiesSubacute cutaneous lupus erythematosusDrug-induced formsPatient's unique presentationTopical antifungal creamAnti-Ro antibodiesVariable systemic involvementRo antibodiesOral agentsOral terbinafineSystemic involvementTopical medicationsErythematous lesionsPsoriasiform lesionsPhysical examinationHistological featuresAntifungal creamOccupational exposureDorsal handNoninfectious Causes
Chow J, deLuise V. Noninfectious Causes. Essentials In Ophthalmology 2017, 93-105. DOI: 10.1007/978-3-319-50404-9_9.Peer-Reviewed Original ResearchPeripheral ulcerative keratitisImmunosuppressive therapyInflammatory processFirst-line immunosuppressive therapyLife-threatening vasculitisNew biologic agentsTNF-alpha inhibitorsConnective tissue diseaseNoninfectious inflammatory diseasesConnective tissue disordersPotential side effectsSystemic corticosteroidsCorneal involvementNoninfectious causesRefractory casesSystemic inflammationAutoimmune destructionBiologic agentsSentinel signSystemic involvementTissue diseaseGlobe integrityImmunomodulatory agentsUlcerative keratitisInflammatory diseases
2014
CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature
James E, Sokhn JG, Gibson JF, Carlson K, Subtil A, Girardi M, Wilson LD, Foss F. CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature. Leukemia & Lymphoma 2014, 56: 951-957. PMID: 24996443, DOI: 10.3109/10428194.2014.938331.Peer-Reviewed Original ResearchConceptsT-cell lymphomaSmall/medium-sized pleomorphic T-cell lymphomaPleomorphic T-cell lymphomaPCSM-TCLSystemic involvementCase seriesWorld Health Organization-European OrganizationIndolent T-cell lymphomaRare T-cell lymphomaLocalized radiationRetrospective case seriesCD7 lossReview of literatureComplete remissionCytotoxic chemotherapyMedian ageFavorable prognosisRetrospective studyTreatment of cancerExcisional biopsyCD4Local modalitiesPatientsLymphomaInvasive features
2013
Primary leptomeningeal lymphoma
Taylor JW, Flanagan EP, O'Neill BP, Siegal T, Omuro A, DeAngelis L, Baehring J, Nishikawa R, Pinto F, Chamberlain M, Hoang-Xuan K, Gonzalez-Aguilar A, Batchelor T, Blay JY, Korfel A, Betensky RA, Lopes MB, Schiff D. Primary leptomeningeal lymphoma. Neurology 2013, 81: 1690-1696. PMID: 24107866, PMCID: PMC3812109, DOI: 10.1212/01.wnl.0000435302.02895.f3.Peer-Reviewed Original ResearchConceptsPrimary leptomeningeal lymphomaPrimary CNS lymphomaLeptomeningeal lymphomaCNS lymphomaLeptomeningeal enhancementCSF cytologyMedian Eastern Cooperative Oncology Group performance statusRare formEastern Cooperative Oncology Group performance statusInternational Primary CNS Lymphoma Collaborative GroupIntra-CSF chemotherapyMedian overall survivalFavorable clinical responseCases of lymphomaOptimal diagnostic evaluationGene rearrangement studiesB-cell lymphomaMultifocal symptomsSalvage treatmentSystemic chemotherapyClinical responseOverall survivalPerformance statusMedian ageSystemic involvement
2008
Fatal Subcutaneous Panniculitis‐Like T‐Cell Lymphoma (Sptcl) with Interface Change and Dermal Mucin, A Dead‐Ringer for Lupus Erythematosus
Ma L, Bandarchi B, Glusac E. Fatal Subcutaneous Panniculitis‐Like T‐Cell Lymphoma (Sptcl) with Interface Change and Dermal Mucin, A Dead‐Ringer for Lupus Erythematosus. Journal Of Cutaneous Pathology 2008, 32: 101-102. DOI: 10.1111/j.0303-6987.2005.320eh.x.Peer-Reviewed Original ResearchSubcutaneous panniculitis-like T-cell lymphomaPanniculitis-like T-cell lymphomaT-cell lymphomaLupus erythematosusLymphoid infiltratesFatal hemophagocytic syndromeInterstitial lymphoid infiltratePulmonary lymphoid infiltratesSimilar immunohistochemical profileVacuolar interface changesDense lymphocytic infiltrateDermal mucin depositionT-cell receptor gamma geneReceptor gamma geneHemophagocytic syndromeLung biopsyLymph nodesLymphocytic infiltrateMucin depositionSystemic involvementDermal mucinUlcerated plaquesMonoclonal rearrangementImmunohistochemical profileSkin biopsies
1989
Catatonic syndrome caused by autoimmune disease: spontaneous remission.
Lichtenstein A, Calish I, Oliveira R, Miguel Filho E, Rocha A. Catatonic syndrome caused by autoimmune disease: spontaneous remission. Clinics 1989, 44: 312-5. PMID: 2486424.Peer-Reviewed Original ResearchConceptsCSF immune complexesAutoimmune diseasesImmune complexesCatatonic syndromeCerebrospinal fluidPositive antinuclear factorSystemic lupus erythematosusAntinuclear factorLupus erythematosusRare manifestationSystemic involvementSystemic manifestationsSpontaneous remissionImmunosuppressive drugsPsychiatric manifestationsCatatonic patientsImmunologic testsCase reportMetabolic disturbancesPsychiatric effectsNucleolar patternSchizophrenic disordersValuable markerDiseasePsychiatric picture
1967
Urticaria as a Sign of Internal Disease
Braverman I. Urticaria as a Sign of Internal Disease. Postgraduate Medicine 1967, 41: 450-454. PMID: 6044098, DOI: 10.1080/00325481.1967.11696947.Peer-Reviewed Original ResearchConceptsConnective tissue diseasePercent of casesChronic urticariaLupus erythematosusSystemic involvementSerum hepatitisTissue diseaseUrticaria pigmentosaInternal diseasesUrticariaUnknown originDiseaseImportant signSignsAdult formDiagnostic featuresArthralgiaErythematosusHepatitisPatientsFeverMalignancyPigmentosa
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply